Skip to main content
Summary
Profile
Financials
Events
Ownership
Options

Company Info

Industry Biotechnology
Sector Health Technology
Employees 410
CEO Dr. Samarth Kulkarni
Address Baarerstrasse 14 , Zug, ZG 6300
Phone 41.41.561.32.77
Website www.crisprtx.com

CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan and Craig Mellow in 2014 and is headquartered in Zug, Switzerland.

Competitors

Company Name 3 Month
%Change
1 Year
%Change
CRISPR Therapeutics AG -33.81% -40.59%
NovoCure Ltd. -30.37% -26.98%
Teva Pharmaceutical Industries Ltd. -12.23% -13.99%
Penumbra, Inc. -9.20% 10.22%
Bausch Health Cos., Inc. -18.13% 24.88%

Statement Summary

as of 4:00 ET PM 11/30/2021
Total Assets (MRQ) 2.8 B
Total Liabilities (MRQ) 308.8 M
Shareholders’ Equity (MRQ) 2.5 B
Total Revenue (Annual) 824.0 K
Net Income (Annual) -127.2 M

Earnings And Estimates

as of 4:00 ET PM 11/30/2021

Current Qtr EPS Estimate -1.69
Current FY EPS Estimate 4.87
Long Term EPS Growth Estimate -2.37
Next Expected Earnings Date 3/11/2022

CRSP vs S&P 500

as of 11/30/2021
Relative To
S&P 500
CRSP
4 Weeks n/a n/a
12 Weeks n/a n/a
YTD n/a n/a

Earnings Surprises

as of 4:00 ET PM 11/30/2021
Fiscal Quarter Estimate Actual Surprise
09/2021 -1.75 -1.67 -4.72%
06/2021 3.52 9.44 +167.99%
03/2021 -1.47 -1.51 +2.53%
12/2020 -1.27 -1.50 +17.82%
09/2020 -1.18 -1.32 +11.39%
06/2020 -0.95 -1.30 +36.74%
03/2020 -1.06 -1.15 +8.89%
12/2019 -0.56 0.51 -190.46%

Financial Strength

as of 4:00 ET PM 11/30/2021
Pre-Tax Margin -15.00
Net Margin 75.29
Operating Margin -15.00
Return On Equity 21.36
Return On Assets 19.13
Inventory Turnover (TTM) 0.00
Sales Growth (MRQ) 23.82

Ratios

as of 4:00 PM ET 11/30/2021
Price/Earnings (TTM) 16.79
Price/Book (MRQ) 2.43
Price/Cash Flow (TTM) 11.21
Book Value (MRQ) 32.86
Quick Ratio (MRQ) 26.18
Current Ratio (MRQ) 26.18
Total Debt/Equity (MRQ) 0.08

Short Interest

as of 3:56 PM ET 12/01/2021
% Short - 0.00%
% Remaining Float - 100.00%
Current Last Month
Short Interest Date n/a n/a
Short Interest Shares 0 0
Short Interest Ratio 0.0 0.0
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00 0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00 0,0.00
Cash from
Activities
0,0.00 0,0.00
Cash from
Fin. Activities
0,0.00 0,0.00

TOTAL ASSETS

TOTAL LIABILITIES

TOTAL EQUITY

Balance Sheet

M Y
ASSETS
Cash And Equivalents 0,0.00
Receivables 0,0.00
Inventories 0,0.00
Other Current Assets 0,0.00
Total Current Assets 0,0.00
Property, Plant & Equipment, Gross 0,0.00
Accumulated Depreciation & Depletion 0,0.00
Property, Plant & Equipment, Net 0,0.00
Intangibles 0,0.00
Other Non-Current Assets 0,0.00
Total Non-Current Assets 0,0.00
TOTAL ASSETS 0,0.00
Liabilities & Shareholder Equity
Accounts Payable 0,0.00
Short Term Debt 0,0.00
Total Current Liabilities 0,0.00
Long Term Debt 0,0.00
Deferred Income Taxes 0,0.00
Other Non-Current Liabilities 0,0.00
Minority Interest 0,0.00
Total Non-Current Liabilities 0,0.00
Preferred Stock Equity 0,0.00
Common Stock Equity 0,0.00
Common Par 0,0.00
Additional Paid In Capital 0,0.00
Cumulative Translation Adjustment 0,0.00
Retained Earnings 0,0.00
Treasury Stock 0,0.00
Other Equity Adjustments 0,0.00
Total Capitalization 0,0.00
TOTAL EQUITY 0,0.00
TOTAL LIABILITIES & STOCK EQUITY 0,0.00
Total Common Shares Outstanding 0,0.00
Preferred Shares 0,0.00
Treasury Shares 0,0.00
Basic Weighted Shares Outstanding 0,0.00
Diluted Weighted Shares Outstanding 0,0.00
Number Of Employees 0,0.00
Number Of Part-Time Employees 0,0.00

TOTAL REVENUES

EBT Excluding Unusual Items

NET INCOME

Income Statement

M Y
Sales 0,0.00
Cost Of Sales 0,0.00
Gross Operating Profit 0,0.00
Selling, General, And Administrative Expenses 0,0.00
Research & Development 0,0.00
Operating Income Before D & A (EBITDA) 0,0.00
Depreciation & Amortization 0,0.00
Interest Income 0,0.00
Other Income - Net 0,0.00
Special Income / Charges 0,0.00
Total Income Before Interest Expenses (EBIT) 0,0.00
Interest Expense 0,0.00
Pre-Tax Income 0,0.00
Income Taxes 0,0.00
Minority Interest 0,0.00
Net Income From Continuing Operations 0,0.00
Net Income From Discontinued Operations 0,0.00
Net Income From Total Operations 0,0.00
Extraordinary Income/Losses 0,0.00
Income From Cum. Effect Of Acct. Change 0,0.00
Income From Tax Loss Carryforward 0,0.00
Other Gains / Losses 0,0.00
Total Net Income 0,0.00
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Preferred Dividends 0,0.00
Net Income Available To Common 0,0.00
Basic EPS From Continuing Ops. 0,0.00
Basic EPS From Discontinued Ops. 0,0.00
Basic EPS From Total Operations 0,0.00
Basic EPS From Extraordinary Inc. 0,0.00
Basic EPS From Cum Effect Of Accounting Change 0,0.00
Basic EPS From Tax Loss Carryf'd. 0,0.00
Basic EPS From Other Gains (Losses) 0,0.00
Basic EPS, Total 0,0.00
Basic Normalized Net Income/Share 0,0.00
EPS From Continuing Ops. 0,0.00
EPS From Discontinued Ops 0,0.00
EPS From Total Ops. 0,0.00
EPS From Extraord. Inc. 0,0.00
EPS From Cum Effect of Accounting Change 0,0.00
EPS From Tax Loss Carfd. 0,0.00
EPS From Other Gains (L) 0,0.00
EPS, Total 0,0.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Dividends Paid Per Share 0,0.00

CASH FROM OPERATIONS

CASH FROM INVESTING ACTIVITIES

CASH FROM FINANCING ACTIVITIES

Cash Flow Statement

M Y
Cash Flow From Operating Activities
Net Income (Loss) 0,0.00
Operating Gains/Losses 0,0.00
Gross Operating Profit 0,0.00
(Increase) Decrease In Receivables 0,0.00
(Increase) Decrease In Inventories 0,0.00
(Increase) Decrease In Other Current Assets 0,0.00
(Decrease) Increase In Other Current Liabilities 0,0.00
(Increase) Decrease In Other Working Capital 0,0.00
Other Non-Cash Items 0,0.00
Net Cash From Continuing Operations 0,0.00
Net Cash From Discontinued Operations 0,0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 0,0.00
Sale Of Property, Plant & Equipment 0,0.00
Cash Used For Investing Activities
Sale Of Short-Term Investments 0,0.00
Purchases Of Property, Plant & Equipment 0,0.00
Acquisitions 0,0.00
Purchases Of Short-Term Investments 0,0.00
Other Cash From Investing Activities 0,0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 0,0.00
Issuance Of Debt 0,0.00
Cash Used For Financing Activities
Issuance Of Capital Stock 0,0.00
Repayment Of Long-Term Debt 0,0.00
Repurchase Of Capital Stock 0,0.00
Payment Of Cash Dividends 0,0.00
Other Financing Charges, Net 0,0.00
Net Cash From Financing Activities 0,0.00
Effect Of Exchange Rate Changes 0,0.00
Net Change In Cash & Cash Equivalents 0,0.00

Earnings Estimates

as of 4:00 ET PM 11/30/2021
Current Qtr
(12/2021)
Next Qtr
(03/2022)
Consensus Estimate $-1.69 $-1.80
# of Estimates 20 11
High Estimate $-0.46 $-1.38
Low Estimate $-2.17 $-2.33
Year Ago EPS $-1.50 $-1.51
Year Over Year Growth Estimate 12.71% 19.43%
Current Yr
(12/2021)
Next Yr
(12/2022)
Consensus Estimate $4.87 $-7.00
# of Estimates 19 19
High Estimate $6.21 $-2.53
Low Estimate $4.49 $-10.78
Year Ago EPS $-5.29 $4.87
Year Over Year Growth Estimate -192.15% -243.68%
Current Qtr
(12/2021)
Next Qtr
(03/2022)
Current Year
(12/2021)
Next Year
(12/2022)
Consensus Estimate $-1.69 $-1.80 $4.87 $-7.00
# of Estimates 20 11 19 19
High Estimate $-0.46 $-1.38 $6.21 $-2.53
Low Estimate $-2.17 $-2.33 $4.49 $-10.78
Year Ago EPS $-1.50 $-1.51 $-5.29 $4.87
Year Over Year Growth Estimate 12.71% 19.43% -192.15% -243.68%

Insider Information Summary

as of 10/31/2021
% Insiders - 8.96%
% Remaining Total Shares - 91.04%
Current 1 Month
Net Insider Transaction 43.27 K -24.74 K
Shares Bought 108.00 K 75.00 K
Shares Sold 64.74 K 99.74 K

Insider Activity

Transaction Date Insider/Title Transaction Type Market Value Shares Average Price Current Holdings

LATEST NEWS

Recent Articles from TheStreet

Four Small-Cap Value Stocks Rallying Into 2017

The Year Small-Caps and Micro-Caps Have Led the Way

In a stellar year for stocks, the little guys have finally seen some progress, Jonathan Heller says.

Gold Crypto thumb

Crypto Crackdown Awaits After SEC 'Fastball' Attempt, Feds Warn

SEC Chairman Gary Gensler and former SEC chair Jay Clayton discuss the unstoppable growth of cryptocurrencies.

Disney Lead

Disney Names New Chairman Amid Bob Iger Departure

Susan Arnold has also served on the boards of McDonald’s Corp. and NBTY Inc.

square fintech app

Jack Dorsey Says Square Is Changing Its Name To Block

CEO of financial payments company announces move just two days after leaving Twitter.

Wells Fargo Execs Encouraged Bankers to Push Overdraft Protection

JPMorgan Chase, Wells Fargo and Bank of America Top Overdraft 'Fee Harvesters'

The three big banks took in 44% of all overdraft fees in its most recent year charted, the Consumer Financial Protection Bureau found.

mortgage rates home house real estate sh

Will Omicron Impact Mortgage Rates?

Investors could seek a flight to safety as new variant whipsaws world markets.

Inflation Lead

Inflation Will Linger, OECD Says, With Omicron Impact Unknown

Organization for Economic Cooperation and Development predicts longer prices for a while, but omicron might change that.

Bret Taylor Marc Benioff Lead

Salesforce Joins the List of Companies With Two CEOs. Here's a Look at How They're Doing

A brief summary of how companies like Netflix, Workday, KKR and Waymo have fared under a twin power sharing arrangement at the top.